The Trump administration has reportedly disrupted over 100 clinical trials. Science News spoke to researchers about the impacts on four of them.

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been ...

Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...

InhaleRX (ASX:IRX) has taken a crucial step to initiate research into IRX-616a – the drug candidate it’s developing to treat ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

A multinational research team of clinicians and scientists from South Korea and Singapore has published positive findings ...

CMND-100 is Clearmind’s proprietary MEAI-based oral drug candidate, developed as a potential breakthrough treatment for AUD. Unlike traditional treatment methods, CMND-100 is designed to offer a novel ...

At UChicago, she now works under Prof. Jeffrey Hubbell on a new method to improve cancer therapy. Using genetic instructions ...

Genesis has gained US Food and Drug Administration (FDA) clearance on an Investigational New Drug (IND) application for a ...

A desi dengue vaccine is undergoing the third phase of clinical trials in India, a top Indian Council of Medical Research ...

Both studies, which are reporting the results of early-stage clinical trials, show that the interventions were safe, and that ...

Sessions addressing supportive care needs for patients with cancer on early phase clinical trials appeared feasible and acceptable in a prospective study.